LONGNECKER BRENT M 4

What Happened
Brent M. Longnecker, a director of Genprex, Inc. (GNPX), sold a total of 18 shares of Genprex common stock in two transactions on April 14, 2026. The sales were 8 shares at $1.23 and 10 shares at $1.23, with reported proceeds shown as $10 and $12 respectively (combined proceeds approximately $22). These transactions are sales (code S) and, per the filing footnote, were made for tax purposes.

Key Details

• Transaction dates and prices: April 14, 2026 — 8 shares @ $1.23 ($10 reported); April 14, 2026 — 10 shares @ $1.23 ($12 reported).
• Total shares sold: 18; total proceeds reported: roughly $22.
• Shares owned after the transaction: not disclosed in the provided excerpt.
• Footnote: F1 — shares sold for tax purposes (tax withholding).
• Filing timeliness: Form 4 filed April 15, 2026 (the day after the transactions), which is timely under normal Form 4 reporting rules.

Context
Sales to cover tax withholding on equity awards are common and do not necessarily indicate a change in an insider’s view of the company. The small dollar value here suggests this was a routine, tax-related disposition rather than a material insider sale.